Asasantin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 26 USDMF, 9 CEP/COS, 6 JDMF, 1 EU WC, 4 KDMF, 32 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

FINISHED DOSAGE FORMULATIONS

452 FDF Dossiers, 117 FDA Orange Book, 110 Europe, 90 Canada, 8 Australia, 25 South Africa, 102 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET;ORAL - 250MG;250MG;65MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 3 Evonik, 13 Rochem International Inc, 31 SPI Pharma, 2 Seqens, 24 DKSH, 3 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 17 Gangwal Healthcare, 15 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 40 BASF, 1 Bioplus Life Sciences, 3 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 16 Gangwal Chemicals, 17 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 12 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 19 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

129 Fillers, Diluents & Binders, 89 Coating Systems & Additives, 57 Thickeners and Stabilizers, 55 Direct Compression, 50 Solubilizers, 50 Controlled & Modified Release, 48 Disintegrants & Superdisintegrants, 46 Taste Masking, 37 Granulation, 37 Parenteral, 34 Topical, 33 Film Formers & Plasticizers, 31 Lubricants & Glidants, 26 Chewable & Orodispersible Aids, 24 Co-Processed Excipients, 16 Emulsifying Agents, 14 API Stability Enhancers, 12 Surfactant & Foaming Agents, 11 Rheology Modifiers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

10 DATA COMPILATION #PharmaFlow, 184 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 70 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

54 APIs, 43 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 JP, 8 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 86162 / DOSAGE - TABLET;ORAL - 325MG;50MG;40MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ASPIRIN(UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E)	ASPIRIN	325mg
BUTALBITAL(UNII: KHS0AZ4JVK) (BUTALBITAL - UNII:KHS0AZ4JVK)	BUTALBITAL	50mg
CAFFEINE(UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E)	CAFFEINE	40mg

Inactive Ingredients

Ingredient Name	A-S Medication Solutions LLC	Bryant Ranch Prepack	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	PD-Rx Pharmaceuticals, Inc.	West-ward Pharmaceutical Corp	Major Pharmaceuticals
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
HYDROGENATED COTTONSEED OIL(Z82Y2C65EA)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
STARCH, CORN(O8232NY3SJ)
TALC(7SEV7J4R1U)

Drug Product Composition: Asasantin

Asasantin

Asasantin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers

26 USDMF

9 CEP/COS

6 JDMF

1 EU WC

4 KDMF

32 NDC API

29 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

35 Drugs in Development

FINISHED DOSAGE FORMULATIONS

452 FDF Dossiers

117 FDA Orange Book

110 Europe

90 Canada

8 Australia

25 South Africa

102 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET;ORAL - 250MG;250MG;65MG

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 Minakem

3 Evonik

13 Rochem International Inc

31 SPI Pharma

2 Seqens

24 DKSH

3 Pharm-RX Chemical

10 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

17 Gangwal Healthcare

15 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

15 Actylis

2 Aeon Procare

3 Alcedo Pharmachem

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

40 BASF

1 Bioplus Life Sciences

3 Clariant

15 Corel Pharma Chem

7 DFE Pharma

3 Doshion Polyscience

3 Finar

16 Gangwal Chemicals

17 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

40 Kerry

5 Kima Chemical

6 Lonza Capsugel

24 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

12 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

47 Roquette

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons